Finance

Lists
METX:CNSX
ME Therapeutics Holdings Inc
CA$2.80
0.00%
(0.00) 1D
Sep 25, 10:38:11 AM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for METX...
Mkt. cap
85.27M
Avg. vol.
966.00
Volume
0.00
52-wk high
CA$8.00
52-wk low
CA$0.79
EPS
-CA$0.05
Mkt. cap
85.27M
Avg. vol.
966.00
Volume
0.00
52-wk high
CA$8.00
52-wk low
CA$0.79
EPS
-CA$0.05
About ME Therapeutics Holdings Inc
CEO-
Employees-
Founded2014
HeadquartersVancouver, British Columbia, Canada
SectorBiotechnology
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Aug 2025
Nov 2025
Feb 2026
May 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
165.08K
141.84K
178.41K
245.32K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
209.58K
213.56K
124.66K
163.76K
Operating expense
401.22K
381.91K
331.36K
436.48K
Total operating expenses
401.22K
381.91K
331.36K
436.48K
Operating income
-401.22K
-381.91K
-331.36K
-436.48K
Other non operating income
57.29K
23.69K
39.50K
35.46K
EBT including unusual items
-338.41K
-354.43K
-289.22K
-398.35K
EBT excluding unusual items
-338.41K
-354.43K
-289.22K
-398.35K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-338.41K
-354.43K
-289.22K
-398.35K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
8.34K
6.10K
4.39K
3.87K
Interest expense
-2.82K
-2.31K
-1.76K
-1.20K
Net interest expenses
5.52K
3.79K
2.63K
2.68K
Depreciation and amortization charges
26.56K
26.52K
28.28K
27.40K
EBITDA
-388.82K
-369.59K
-317.26K
-423.28K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps